ABclonal Biotechnology Co., Ltd. was established in 2011 as a provider of life science solutions, dedicated to offering professional and reliable products and services for global life science basic research, translational medicine, diagnostics, pharmaceuticals, and other fields. The company’s core business encompasses research antibodies, molecular enzymes, NGS library preparation and automation solutions, in vitro diagnostic raw materials, analytical instruments for protein and nucleic acid testing, consumables, and antibody discovery services, serving over 40 countries and regions worldwide.
ABclonal
